Form 8-K - Current report:
SEC Accession No. 0001628280-25-011465
Filing Date
2025-03-10
Accepted
2025-03-10 08:10:23
Documents
66
Period of Report
2025-03-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20250310.htm   iXBRL 8-K 28283
2 EX-99.1 corporatepresentationmar.htm EX-99.1 53545
6 corporatepresentationmar001.jpg GRAPHIC 96500
7 corporatepresentationmar002.jpg GRAPHIC 307957
8 corporatepresentationmar003.jpg GRAPHIC 114763
9 corporatepresentationmar004.jpg GRAPHIC 98959
10 corporatepresentationmar005.jpg GRAPHIC 92619
11 corporatepresentationmar006.jpg GRAPHIC 140707
12 corporatepresentationmar007.jpg GRAPHIC 96076
13 corporatepresentationmar008.jpg GRAPHIC 79048
14 corporatepresentationmar009.jpg GRAPHIC 121803
15 corporatepresentationmar010.jpg GRAPHIC 90387
16 corporatepresentationmar011.jpg GRAPHIC 52027
17 corporatepresentationmar012.jpg GRAPHIC 75395
18 corporatepresentationmar013.jpg GRAPHIC 98857
19 corporatepresentationmar014.jpg GRAPHIC 112795
20 corporatepresentationmar015.jpg GRAPHIC 107194
21 corporatepresentationmar016.jpg GRAPHIC 124423
22 corporatepresentationmar017.jpg GRAPHIC 108271
23 corporatepresentationmar018.jpg GRAPHIC 88865
24 corporatepresentationmar019.jpg GRAPHIC 117759
25 corporatepresentationmar020.jpg GRAPHIC 76221
26 corporatepresentationmar021.jpg GRAPHIC 141355
27 corporatepresentationmar022.jpg GRAPHIC 40346
28 corporatepresentationmar023.jpg GRAPHIC 119376
29 corporatepresentationmar024.jpg GRAPHIC 106709
30 corporatepresentationmar025.jpg GRAPHIC 42983
31 corporatepresentationmar026.jpg GRAPHIC 106406
32 corporatepresentationmar027.jpg GRAPHIC 100787
33 corporatepresentationmar028.jpg GRAPHIC 125670
34 corporatepresentationmar029.jpg GRAPHIC 112718
35 corporatepresentationmar030.jpg GRAPHIC 118650
36 corporatepresentationmar031.jpg GRAPHIC 43049
37 corporatepresentationmar032.jpg GRAPHIC 92380
38 corporatepresentationmar033.jpg GRAPHIC 111494
39 corporatepresentationmar034.jpg GRAPHIC 111145
40 corporatepresentationmar035.jpg GRAPHIC 100478
41 corporatepresentationmar036.jpg GRAPHIC 108401
42 corporatepresentationmar037.jpg GRAPHIC 102072
43 corporatepresentationmar038.jpg GRAPHIC 103956
44 corporatepresentationmar039.jpg GRAPHIC 97200
45 corporatepresentationmar040.jpg GRAPHIC 124947
46 corporatepresentationmar041.jpg GRAPHIC 130654
47 corporatepresentationmar042.jpg GRAPHIC 131762
48 corporatepresentationmar043.jpg GRAPHIC 38814
49 corporatepresentationmar044.jpg GRAPHIC 90144
50 corporatepresentationmar045.jpg GRAPHIC 34834
51 corporatepresentationmar046.jpg GRAPHIC 97792
52 corporatepresentationmar047.jpg GRAPHIC 135576
53 corporatepresentationmar048.jpg GRAPHIC 137262
54 corporatepresentationmar049.jpg GRAPHIC 122832
55 corporatepresentationmar050.jpg GRAPHIC 132599
56 corporatepresentationmar051.jpg GRAPHIC 72139
57 corporatepresentationmar052.jpg GRAPHIC 32206
  Complete submission text file 0001628280-25-011465.txt   7620950

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20250310.xsd EX-101.SCH 1776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20250310_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20250310_pre.xml EX-101.PRE 12504
68 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20250310_htm.xml XML 2719
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 25722225
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)